Nature Reviews Gastroenterology & Hepatology
Nature Reviews Gastroenterology and Hepatology is a peer-reviewed journal for gastroenterologists, hepatologists and affiliated health-care professionals. The journal delivers timely interpretations of key developments in gastroenterology, hepatology and related areas of study. Nature Reviews Gastroenterology and Hepatology is published monthly in print and online and includes commissioned news, commentary and opinion pieces and comprehensive reviews. Articles are subject to rigorous peer-review and/or review by in-house editors. Topics covered include the pathology, diagnosis and treatment of diseases of the gastrointestinal tract, liver, pancreas, gall bladder and biliary tract, such as functional gastrointestinal disorders, inflammatory diseases, cancer, infection and nutritional disorders.
http://feeds.nature.com/nrgastro/rss/current
Nature Publishing Group
en
© 2024 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.
Nature Reviews Gastroenterology & Hepatology
© 2024 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.
permissions@nature.com
Nature Reviews Gastroenterology & Hepatology
https://www.nature.com/uploads/product/nrgastro/rss.gif
http://feeds.nature.com/nrgastro/rss/current
-
https://www.nature.com/articles/s41575-024-00918-z
Nature Reviews Gastroenterology & Hepatology, Published online: 18 March 2024; doi:10.1038/s41575-024-00918-zFatty liver disease is one of the most common liver diseases in the Middle East and North Africa region, and globally. Unfortunately, there is a lack of awareness regarding this condition. The nomenclature changes for NAFLD (to MAFLD or MASLD) have gained considerable attention in the hepatology community. Here, we present our point of view on this ongoing change and debate.]]>
Yasser FouadSalma BarakatAlmoutaz HashimHasmik Ghazinyan
doi:10.1038/s41575-024-00918-z
Nature Reviews Gastroenterology & Hepatology, Published online: 2024-03-18; | doi:10.1038/s41575-024-00918-z
2024-03-18
Nature Reviews Gastroenterology & Hepatology
10.1038/s41575-024-00918-z
https://www.nature.com/articles/s41575-024-00918-z
-
https://www.nature.com/articles/s41575-024-00900-9
Nature Reviews Gastroenterology & Hepatology, Published online: 14 March 2024; doi:10.1038/s41575-024-00900-9In this article, the authors discuss the use of total neoadjuvant therapy for locally advanced rectal cancer. They highlight ongoing trials and discuss future treatment options, including the potential use of multi-omics and artificial intelligence to facilitate treatment selection and prediction of response.]]>
Yoshinori KagawaJ. Joshua SmithEmmanouil FokasJun WatanabeAndrea CercekFlorian R. GretenHideaki BandoQian ShiJulio Garcia-AguilarPaul B. RomesserNatally HorvatHanna SanoffWilliam HallTakeshi KatoClaus RödelArvind DasariTakayuki Yoshino
doi:10.1038/s41575-024-00900-9
Nature Reviews Gastroenterology & Hepatology, Published online: 2024-03-14; | doi:10.1038/s41575-024-00900-9
2024-03-14
Nature Reviews Gastroenterology & Hepatology
10.1038/s41575-024-00900-9
https://www.nature.com/articles/s41575-024-00900-9
-
https://www.nature.com/articles/s41575-024-00913-4
Nature Reviews Gastroenterology & Hepatology, Published online: 14 March 2024; doi:10.1038/s41575-024-00913-4Ageing and senescence are major risk factors for liver disease development. This Review provides a comprehensive overview of hepatic senescence, its role in liver disease progression and hepatocellular carcinoma, and discusses potential therapeutic strategies.]]>
David Sanfeliu-RedondoAlbert Gibert-RamosJordi Gracia-Sancho
doi:10.1038/s41575-024-00913-4
Nature Reviews Gastroenterology & Hepatology, Published online: 2024-03-14; | doi:10.1038/s41575-024-00913-4
2024-03-14
Nature Reviews Gastroenterology & Hepatology
10.1038/s41575-024-00913-4
https://www.nature.com/articles/s41575-024-00913-4
-
https://www.nature.com/articles/s41575-024-00917-0
Nature Reviews Gastroenterology & Hepatology, Published online: 13 March 2024; doi:10.1038/s41575-024-00917-0ECCO’24]]>
Katrina Ray
doi:10.1038/s41575-024-00917-0
Nature Reviews Gastroenterology & Hepatology, Published online: 2024-03-13; | doi:10.1038/s41575-024-00917-0
2024-03-13
Nature Reviews Gastroenterology & Hepatology
10.1038/s41575-024-00917-0
https://www.nature.com/articles/s41575-024-00917-0
-
https://www.nature.com/articles/s41575-024-00907-2
Nature Reviews Gastroenterology & Hepatology, Published online: 13 March 2024; doi:10.1038/s41575-024-00907-2In this Perspective, Ginès and colleagues discuss liver fibrosis screening programmes using insights from colorectal and lung cancer screening.]]>
Maja ThielePatrick S. KamathIsabel GrauperaAntoni CastellsHarry J. de KoningMiquel Serra-BurrielFrank LammertPere Ginès
doi:10.1038/s41575-024-00907-2
Nature Reviews Gastroenterology & Hepatology, Published online: 2024-03-13; | doi:10.1038/s41575-024-00907-2
2024-03-13
Nature Reviews Gastroenterology & Hepatology
10.1038/s41575-024-00907-2
https://www.nature.com/articles/s41575-024-00907-2
-
https://www.nature.com/articles/s41575-024-00906-3
Nature Reviews Gastroenterology & Hepatology, Published online: 11 March 2024; doi:10.1038/s41575-024-00906-3Here, an overview of group 3 innate lymphoid cells (ILC3s) is provided in gastrointestinal health and disease, highlighting their role in tissue physiology, immunity, inflammation and cancer. The biology and physiological function of ILC3s are described across different states and diseases along with a discussion on opportunities for therapeutic targeting.]]>
Veronika HornGregory F. Sonnenberg
doi:10.1038/s41575-024-00906-3
Nature Reviews Gastroenterology & Hepatology, Published online: 2024-03-11; | doi:10.1038/s41575-024-00906-3
2024-03-11
Nature Reviews Gastroenterology & Hepatology
10.1038/s41575-024-00906-3
https://www.nature.com/articles/s41575-024-00906-3
-
https://www.nature.com/articles/s41575-024-00916-1
Nature Reviews Gastroenterology & Hepatology, Published online: 07 March 2024; doi:10.1038/s41575-024-00916-12023 FDA approvals in gastroenterology and hepatology]]>
Eleni Kotsiliti
doi:10.1038/s41575-024-00916-1
Nature Reviews Gastroenterology & Hepatology, Published online: 2024-03-07; | doi:10.1038/s41575-024-00916-1
2024-03-07
Nature Reviews Gastroenterology & Hepatology
10.1038/s41575-024-00916-1
https://www.nature.com/articles/s41575-024-00916-1
-
https://www.nature.com/articles/s41575-024-00893-5
Nature Reviews Gastroenterology & Hepatology, Published online: 22 February 2024; doi:10.1038/s41575-024-00893-5In this Review, Whelan and colleagues summarize and discuss evidence for the effects of ultra-processed foods and food additives on gut health and diseases, including inflammatory bowel disease, colorectal cancer and irritable bowel syndrome.]]>
Kevin WhelanAaron S. BancilJames O. LindsayBenoit Chassaing
doi:10.1038/s41575-024-00893-5
Nature Reviews Gastroenterology & Hepatology, Published online: 2024-02-22; | doi:10.1038/s41575-024-00893-5
2024-02-22
Nature Reviews Gastroenterology & Hepatology
10.1038/s41575-024-00893-5
https://www.nature.com/articles/s41575-024-00893-5